Market Tracker

07/29 3:50pm ET
36.92
BATS BZX Real-Time Price
As of 3:50pm ET
 +0.25 / +0.68%
Today’s Change
28.25
Today|||52-Week Range
37.19
+14.37%
Year-to-Date
PFE Regular Dividend: PFE will begin trading ex-dividend on 08/03/16 with a $0.30 dividend payable to shareholders of record as of 08/05/16.
Buy Merck on Near-Term Weakness
11:45am / TheStreet.com - Paid Partner Content
3 Stocks Pushing The Health Care Sector Downward
Jul 28 / TheStreet.com - Paid Partner Content
3 Great Stocks For Retirees
10:03am / MotleyFool.com - Paid Partner Content
Jim Cramer: Second-Quarter Earnings Have Been Mixed
Jul 28 / TheStreet.com - Paid Partner Content
Better Buy: Regeneron Pharmaceuticals vs. Pfizer
9:46am / MotleyFool.com - Paid Partner Content
Bristol-Myers (BMY) Beats on Q2 Earnings, Lifts Outlook
Jul 28 / Zacks.com - Paid Partner Content
Sanofi Quarterly Earnings, Sales Slide, Reiterates Discipline on Medivation
4:04am / TheStreet.com - Paid Partner Content
Better Buy: Johnson & Johnson vs. Pfizer
Jul 28 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Stock Down, Partners with Western Oncolytics on Cancer Technology
Jul 28 / TheStreet.com - Paid Partner Content
Allergan Cures Its Ailing Chart
Jul 28 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close36.67
Today’s open36.71
Day’s range36.65 - 36.92
Volume1,064,761
Average volume (3 months)33,008,427
Market cap$223.5B
Dividend yield3.25%
Data as of 3:50pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+11.39%
Earnings growth (next 5 years)+6.80%
Revenue growth (last year)-1.52%
P/E ratio30.2
Price/Sales4.13
Price/Book3.52

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+1.27+1.55%
AGNPRAAllergan plc-6.45-0.72%
MRKMerck+0.34+0.58%
BMYBristol-Myers Squibb+0.34+0.46%
Data as of 3:50pm ET, 07/29/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.61
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts